glp-1 market news november 2025 pharma today A network meta-analysis backed weight-loss benefits with several Glucagon Like Peptide-1 (GLP-1) Agonists

Some of this energy ends up stored as visceral fat, adding petrol to the fire

Available from: alzinfo.org How GLP-1s Could Transform Alzheimers Treatment. BrightFocus Foundation

Obesity causes organ dysfunction via several pathophysiological mechanisms, ranging from the physical impact of increased adipose tissue mass, the presence of ectopic fat within tissues and organs, metabolic effects, inflammatory mechanisms, and psychological consequences [4,5]

Back Gilbert, B, Rosenthal, D (5 March 2024) 'The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)', Acquired podcast, ACQ2 Episode